Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:08
07/30/21
07/30
12:08
07/30/21
12:08
AMZN

Amazon.com

$3,341.78 /

-257.53 (-7.15%)

, PINS

Pinterest

$58.59 /

-13.33 (-18.53%)

, PG

Procter & Gamble

$143.15 /

+3.82 (+2.74%)

, CVX

Chevron

$101.46 /

-1.08 (-1.05%)

, XOM

Exxon Mobil

$57.54 /

-1.37 (-2.33%)

, DUOL

Duolingo

$136.26 /

-0.69 (-0.50%)

, TSLA

Tesla

$691.25 /

+13.9 (+2.05%)

, NVDA

Nvidia

$194.00 /

-2.61 (-1.33%)

, UBER

Uber

$43.97 /

-0.72 (-1.61%)

, BAYRY

Bayer

$15.13 /

+0.24 (+1.61%)

, TEAM

Atlassian

$331.75 /

+64.96 (+24.35%)

, KLAC

KLA Corp.

$342.56 /

+23.295 (+7.30%)

, MAXR

Maxar Technologies

$36.57 /

+1.56 (+4.46%)

, UPWK

Upwork

$49.90 /

-7.56 (-13.16%)

, SAVA

Cassava Sciences

$88.25 /

-15.16 (-14.66%)

, ABBV

AbbVie

$116.80 /

-2.09 (-1.76%)

, GILD

Gilead

$68.54 /

-1.32 (-1.89%)

, TMUS

T-Mobile

$144.78 /

+0.19 (+0.13%)

, ZEN

Zendesk

$129.15 /

-21.57 (-14.31%)

, LBTYA

Liberty Global

$26.76 /

+1 (+3.88%)

, LBTYK

Liberty Global

$26.77 /

+1.085 (+4.22%)

, MDLZ

Mondelez

$63.38 /

+0.05 (+0.08%)

, NOK

Nokia

$6.08 /

+0.035 (+0.58%)

, PFPT

Proofpoint

$174.64 /

+0.015 (+0.01%)

Get caught up quickly on…

ShowHide Related Items >><<
ZEN Zendesk
$129.15 /

-21.57 (-14.31%)

XOM Exxon Mobil
$57.54 /

-1.37 (-2.33%)

UPWK Upwork
$49.90 /

-7.56 (-13.16%)

UBER Uber
$43.97 /

-0.72 (-1.61%)

TSLA Tesla
$691.25 /

+13.9 (+2.05%)

TMUS T-Mobile
$144.78 /

+0.19 (+0.13%)

TEAM Atlassian
$331.75 /

+64.96 (+24.35%)

SAVA Cassava Sciences
$88.25 /

-15.16 (-14.66%)

PINS Pinterest
$58.59 /

-13.33 (-18.53%)

PG Procter & Gamble
$143.15 /

+3.82 (+2.74%)

PFPT Proofpoint
$174.64 /

+0.015 (+0.01%)

NVDA Nvidia
$194.00 /

-2.61 (-1.33%)

NOK Nokia
$6.08 /

+0.035 (+0.58%)

MDLZ Mondelez
$63.38 /

+0.05 (+0.08%)

MAXR Maxar Technologies
$36.57 /

+1.56 (+4.46%)

LBTYA Liberty Global
$26.76 /

+1 (+3.88%)

KLAC KLA Corp.
$342.56 /

+23.295 (+7.30%)

GILD Gilead
$68.54 /

-1.32 (-1.89%)

CVX Chevron
$101.46 /

-1.08 (-1.05%)

BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

AMZN Amazon.com
$3,341.78 /

-257.53 (-7.15%)

ABBV AbbVie
$116.80 /

-2.09 (-1.76%)

AMZN Amazon.com
$3,341.78 /

-257.53 (-7.15%)

08:48 Today JPMorgan
Amazon.com price target lowered to $4,100 from $4,600 at JPMorgan
08:32 Today Cowen
Amazon.com price target lowered to $4400 from $4600 at Cowen
08:01 Today UBS
Amazon.com price target lowered to $4,020 from $4,350 at UBS
07:56 Today Oppenheimer
Amazon.com price target lowered to $4,200 from $4,400 at Oppenheimer
PINS Pinterest
$58.59 /

-13.33 (-18.53%)

09:35 Today
Fly Intel: Top five analyst downgrades
08:36 Today MKM Partners
Pinterest price target lowered to $74 from $90 at MKM Partners
08:31 Today Morgan Stanley
Pinterest price target lowered to $77 from $83 at Morgan Stanley
08:09 Today Wedbush
Pinterest price target lowered to $70 from $91 at Wedbush
PG Procter & Gamble
$143.15 /

+3.82 (+2.74%)

06/23/21 UBS
Procter & Gamble initiated with a Neutral at UBS
04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 Roth Capital
PureCycle Technologies initiated with a Buy at Roth Capital
04/21/21 Citi
Procter & Gamble downgraded to Neutral from Buy at Citi
CVX Chevron
$101.46 /

-1.08 (-1.05%)

07/23/21 Piper Sandler
Chevron price target raised to $137 from $126 at Piper Sandler
07/22/21
Fly Intel: Top five analyst downgrades
07/22/21 Redburn
Chevron upgraded to Buy from Neutral at Redburn
07/22/21 HSBC
Chevron downgraded to Hold from Buy at HSBC
XOM Exxon Mobil
$57.54 /

-1.37 (-2.33%)

07/23/21 Piper Sandler
Exxon Mobil price target raised to $69 from $63 at Piper Sandler
07/22/21 HSBC
Exxon Mobil price target lowered to $57 from $65 at HSBC
07/12/21
Fly Intel: Top five analyst initiations
07/12/21 BMO Capital
Exxon Mobil initiated with a Market Perform at BMO Capital
DUOL Duolingo
$136.26 /

-0.69 (-0.50%)

TSLA Tesla
$691.25 /

+13.9 (+2.05%)

07/29/21 DZ Bank
Tesla upgraded to Buy from Sell at DZ Bank
07/28/21 Citi
Tesla price target raised to $209 from $175 at Citi
07/27/21 Needham
Tesla saw improvement on cost structure, valuation still too high, says Needham
07/27/21 Roth Capital
Competitive news flow likely drives Tesla 2H21 volatility, says Roth Capital
NVDA Nvidia
$194.00 /

-2.61 (-1.33%)

07/23/21 Jefferies
Intel price target lowered to $52 from $54 at Jefferies
07/23/21 Argus
Nvidia price target raised to $230 from $175 at Argus
07/22/21 Citi
Nvidia price target raised to $223 from $180 at Citi
07/21/21 Oppenheimer
Nvidia price target lowered to $235 from $925 at Oppenheimer
UBER Uber
$43.97 /

-0.72 (-1.61%)

07/22/21 Stifel
Acquisition of Transplace expands Uber Freight's capabilities, says Stifel
07/21/21 DA Davidson
HyreCar initiated with a Buy at DA Davidson
07/01/21 Cowen
Uber target raised to $80 on rising mobility users at Cowen
07/01/21 Arete
Uber upgraded to Neutral from Sell at Arete
BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
TEAM Atlassian
$331.75 /

+64.96 (+24.35%)

07:52 Today Canaccord
Atlassian price target raised to $325 from $275 at Canaccord
07:34 Today Truist
Atlassian price target raised to $270 from $200 at Truist
06:37 Today Mizuho
Atlassian price target raised to $370 from $310 at Mizuho
06:05 Today Piper Sandler
Atlassian price target raised to $308 from $259 at Piper Sandler
KLAC KLA Corp.
$342.56 /

+23.295 (+7.30%)

09:35 Today
Fly Intel: Top five analyst upgrades
08:42 Today Cowen
KLA Corp. price target raised to $355 from $335 at Cowen
07:30 Today Needham
KLA Corp. upgraded to Buy from Hold at Needham
06:54 Today Deutsche Bank
KLA Corp. price target raised to $400 from $375 at Deutsche Bank
MAXR Maxar Technologies
$36.57 /

+1.56 (+4.46%)

07/15/21 Morgan Stanley
Maxar Technologies initiated with an Overweight at Morgan Stanley
07/14/21 Baird
Baird starts Maxar Technologies at Neutral, cautious ahead of Legion launch
07/14/21 Baird
Maxar Technologies initiated with a Neutral at Baird
06/22/21 BofA
BofA starts Maxar Technologies at Neutral, sees runway along with risks
UPWK Upwork
$49.90 /

-7.56 (-13.16%)

08:52 Today MKM Partners
Upwork price target raised to $65 from $58 at MKM Partners
07/01/21 BTIG
Upwork price target raised to $76 from $65 at BTIG
05/05/21 BTIG
Upwork price target lowered to $65 from $75 at BTIG
02/25/21 Citi
Upwork price target raised to $75 from $48 at Citi
SAVA Cassava Sciences
$88.25 /

-15.16 (-14.66%)

07:55 Today B. Riley
Cassava Sciences data represents 'home run scenario,' says B. Riley
07/20/21 H.C. Wainwright
Cassava Sciences price target raised to $124 from $97 at H.C. Wainwright
07/15/21
Fly Intel: Top five analyst downgrades
07/15/21 Cantor Fitzgerald
Cassava Sciences downgraded to Neutral from Overweight at Cantor Fitzgerald
ABBV AbbVie
$116.80 /

-2.09 (-1.76%)

07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/26/21 Truist
AbbVie assumed with a Buy at Truist
07/02/21
Fly Intel: Top five analyst initiations
07/02/21 Daiwa
AbbVie initiated with an Outperform at Daiwa
GILD Gilead
$68.54 /

-1.32 (-1.89%)

07:54 Today BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07:09 Today RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
TMUS T-Mobile
$144.78 /

+0.19 (+0.13%)

09:29 Today Truist
T-Mobile price target raised to $175 from $150 at Truist
06:28 Today RBC Capital
T-Mobile upgraded to Outperform from Sector Perform at RBC Capital
06:09 Today RBC Capital
T-Mobile upgraded to Outperform from Sector Perform at RBC Capital
ZEN Zendesk
$129.15 /

-21.57 (-14.31%)

05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 UBS
Zendesk upgraded to Buy from Neutral at UBS
04/30/21 Piper Sandler
Zendesk price target raised to $186 from $180 at Piper Sandler
04/22/21 Wolfe Research
Zendesk initiated with an Outperform at Wolfe Research
LBTYA Liberty Global
$26.76 /

+1 (+3.88%)

07/29/21 Deutsche Bank
Liberty Global named short-term investment idea at Deutsche Bank
06/23/21 JPMorgan
Liberty Global resumed with an Overweight at JPMorgan
05/07/21 Barclays
Liberty Global price target raised to $35 from $32 at Barclays
05/06/21 Pivotal Research
Liberty Global 'moving in the right direction,' says Pivotal Research
LBTYK Liberty Global
$26.77 /

+1.085 (+4.22%)

09/29/20 Pivotal Research
Liberty Global price target raised to $40 from $30 at Pivotal Research
MDLZ Mondelez
$63.38 /

+0.05 (+0.08%)

04:51 Today Goldman Sachs
Mondelez downgraded to Buy from Conviction Buy at Goldman Sachs
07/19/21 Morgan Stanley
Morgan Stanley equity strategist upgrades Consumer Staples, downgrades Materials
07/19/21 Deutsche Bank
Mondelez price target raised to $71 from $70 at Deutsche Bank
NOK Nokia
$6.08 /

+0.035 (+0.58%)

07:20 Today Cowen
Cowen upgrades Nokia to Outperform on favorable demand, turnaround progress
05:51 Today Cowen
Nokia upgraded to Outperform from Market Perform at Cowen
07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 JPMorgan
JPMorgan upgrades Nokia on 'more room to run' for mobile turnaround
PFPT Proofpoint
$174.64 /

+0.015 (+0.01%)

04:52 Today JMP Securities
Proofpoint downgraded to Market Perform from Outperform at JMP Securities
05/24/21 Baird
Proofpoint downgraded to Neutral from Outperform at Baird
04/27/21 Truist
Proofpoint downgraded to Hold from Buy at Truist
ZEN Zendesk
$129.15 /

-21.57 (-14.31%)

XOM Exxon Mobil
$57.54 /

-1.37 (-2.33%)

UPWK Upwork
$49.90 /

-7.56 (-13.16%)

UBER Uber
$43.97 /

-0.72 (-1.61%)

TSLA Tesla
$691.25 /

+13.9 (+2.05%)

TMUS T-Mobile
$144.78 /

+0.19 (+0.13%)

TEAM Atlassian
$331.75 /

+64.96 (+24.35%)

SAVA Cassava Sciences
$88.25 /

-15.16 (-14.66%)

PINS Pinterest
$58.59 /

-13.33 (-18.53%)

PG Procter & Gamble
$143.15 /

+3.82 (+2.74%)

PFPT Proofpoint
$174.64 /

+0.015 (+0.01%)

NVDA Nvidia
$194.00 /

-2.61 (-1.33%)

NOK Nokia
$6.08 /

+0.035 (+0.58%)

MDLZ Mondelez
$63.38 /

+0.05 (+0.08%)

MAXR Maxar Technologies
$36.57 /

+1.56 (+4.46%)

LBTYA Liberty Global
$26.76 /

+1 (+3.88%)

KLAC KLA Corp.
$342.56 /

+23.295 (+7.30%)

GILD Gilead
$68.54 /

-1.32 (-1.89%)

CVX Chevron
$101.46 /

-1.08 (-1.05%)

BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

AMZN Amazon.com
$3,341.78 /

-257.53 (-7.15%)

ABBV AbbVie
$116.80 /

-2.09 (-1.76%)

  • 29
    Jul
  • 28
    Jul
  • 18
    Mar
  • 08
    Jan
  • 13
    Nov
XOM Exxon Mobil
$57.54 /

-1.37 (-2.33%)

UPWK Upwork
$49.90 /

-7.56 (-13.16%)

UBER Uber
$43.97 /

-0.72 (-1.61%)

TSLA Tesla
$691.25 /

+13.9 (+2.05%)

TMUS T-Mobile
$144.78 /

+0.19 (+0.13%)

SAVA Cassava Sciences
$88.25 /

-15.16 (-14.66%)

PINS Pinterest
$58.59 /

-13.33 (-18.53%)

PG Procter & Gamble
$143.15 /

+3.82 (+2.74%)

PFPT Proofpoint
$174.64 /

+0.015 (+0.01%)

NVDA Nvidia
$194.00 /

-2.61 (-1.33%)

NOK Nokia
$6.08 /

+0.035 (+0.58%)

MDLZ Mondelez
$63.38 /

+0.05 (+0.08%)

MAXR Maxar Technologies
$36.57 /

+1.56 (+4.46%)

GILD Gilead
$68.54 /

-1.32 (-1.89%)

DUOL Duolingo
$136.26 /

-0.69 (-0.50%)

CVX Chevron
$101.46 /

-1.08 (-1.05%)

BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

AMZN Amazon.com
$3,341.78 /

-257.53 (-7.15%)

ABBV AbbVie
$116.80 /

-2.09 (-1.76%)

ZEN Zendesk
$129.15 /

-21.57 (-14.31%)

XOM Exxon Mobil
$57.54 /

-1.37 (-2.33%)

UPWK Upwork
$49.90 /

-7.56 (-13.16%)

UBER Uber
$43.97 /

-0.72 (-1.61%)

TSLA Tesla
$691.25 /

+13.9 (+2.05%)

TMUS T-Mobile
$144.78 /

+0.19 (+0.13%)

TEAM Atlassian
$331.75 /

+64.96 (+24.35%)

SAVA Cassava Sciences
$88.25 /

-15.16 (-14.66%)

PINS Pinterest
$58.59 /

-13.33 (-18.53%)

PG Procter & Gamble
$143.15 /

+3.82 (+2.74%)

PFPT Proofpoint
$174.64 /

+0.015 (+0.01%)

NVDA Nvidia
$194.00 /

-2.61 (-1.33%)

NOK Nokia
$6.08 /

+0.035 (+0.58%)

MDLZ Mondelez
$63.38 /

+0.05 (+0.08%)

MAXR Maxar Technologies
$36.57 /

+1.56 (+4.46%)

KLAC KLA Corp.
$342.56 /

+23.295 (+7.30%)

GILD Gilead
$68.54 /

-1.32 (-1.89%)

DUOL Duolingo
$136.26 /

-0.69 (-0.50%)

CVX Chevron
$101.46 /

-1.08 (-1.05%)

AMZN Amazon.com
$3,341.78 /

-257.53 (-7.15%)

ABBV AbbVie
$116.80 /

-2.09 (-1.76%)

XOM Exxon Mobil
$57.54 /

-1.37 (-2.33%)

UPWK Upwork
$49.90 /

-7.56 (-13.16%)

UBER Uber
$43.97 /

-0.72 (-1.61%)

TSLA Tesla
$691.25 /

+13.9 (+2.05%)

TMUS T-Mobile
$144.78 /

+0.19 (+0.13%)

TEAM Atlassian
$331.75 /

+64.96 (+24.35%)

SAVA Cassava Sciences
$88.25 /

-15.16 (-14.66%)

PINS Pinterest
$58.59 /

-13.33 (-18.53%)

PG Procter & Gamble
$143.15 /

+3.82 (+2.74%)

NVDA Nvidia
$194.00 /

-2.61 (-1.33%)

NOK Nokia
$6.08 /

+0.035 (+0.58%)

MDLZ Mondelez
$63.38 /

+0.05 (+0.08%)

MAXR Maxar Technologies
$36.57 /

+1.56 (+4.46%)

KLAC KLA Corp.
$342.56 /

+23.295 (+7.30%)

GILD Gilead
$68.54 /

-1.32 (-1.89%)

CVX Chevron
$101.46 /

-1.08 (-1.05%)

AMZN Amazon.com
$3,341.78 /

-257.53 (-7.15%)

ABBV AbbVie
$116.80 /

-2.09 (-1.76%)

Initiation
Royalty Pharma initiated with a Buy at Tigress Financial » 09:31
07/30/21
07/30
09:31
07/30/21
09:31
RPRX

Royalty Pharma

$38.23 /

-0.25 (-0.65%)

Tigress Financial analyst…

Tigress Financial analyst Ivan Feinseth initiated coverage of Royalty Pharma with a Buy rating and $50 price target. The company's "unique business model and history of success" presents investors an opportunity to participate in royalty streams from both development-stage growth and mature stage biopharma royalties, Feinseth said.

ShowHide Related Items >><<
RPRX Royalty Pharma
$38.23 /

-0.25 (-0.65%)

RPRX Royalty Pharma
$38.23 /

-0.25 (-0.65%)

06/03/21 SVB Leerink
MorphoSys upgraded to Outperform at SVB Leerink
11/09/20
Fly Intel: Top five analyst upgrades
11/09/20 UBS
Royalty Pharma upgraded to Buy from Neutral at UBS
RPRX Royalty Pharma
$38.23 /

-0.25 (-0.65%)

  • 16
    Oct
Recommendations
LabCorp price target raised to $350 from $330 at Truist » 09:19
07/30/21
07/30
09:19
07/30/21
09:19
LH

LabCorp

$294.69 /

+11.245 (+3.97%)

Truist analyst David…

Truist analyst David MacDonald raised the firm's price target on LabCorp to $350 from $330 and keeps a Buy rating on the shares. The company's Q2 results were marked by a sharp rebound in base business and continued strong cash flow, the analyst tells investors in a research note, adding that he is also positive on the valuation risk/reward as continued strong drug development growth "put upward pressure" on the stock's multiple over time.

ShowHide Related Items >><<
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

07:06 Today Deutsche Bank
LabCorp price target raised to $330 from $297 at Deutsche Bank
06:39 Today Mizuho
LabCorp price target raised to $318 from $310 at Mizuho
05/20/21 Argus
LabCorp price target raised to $295 from $270 at Argus
05/18/21 Wells Fargo
Amazon could have interest in diagnostics beyond COVID, says Wells Fargo
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

Recommendations
DexCom price target raised to $500 from $485 at SVB Leerink » 08:20
07/30/21
07/30
08:20
07/30/21
08:20
DXCM

DexCom

$456.17 /

-3.25 (-0.71%)

, ABT

Abbott

$121.11 /

+0.61 (+0.51%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

ABT Abbott
$121.11 /

+0.61 (+0.51%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

07:46 Today Oppenheimer
DexCom price target raised to $525 from $500 at Oppenheimer
07:45 Today Canaccord
DexCom price target raised to $500 from $455 at Canaccord
07:39 Today Raymond James
DexCom price target raised to $515 from $466 at Raymond James
07:05 Today Baird
DexCom price target raised to $520 from $460 at Baird
ABT Abbott
$121.11 /

+0.61 (+0.51%)

07/23/21 Raymond James
Abbott price target raised to $128 from $116 at Raymond James
07/12/21 Wells Fargo
Abbott price target raised to $135 from $125 at Wells Fargo
07/01/21 Piper Sandler
DexCom settlement with Abbott could be lucrative, says Piper Sandler
07/01/21 Stephens
Stephens says DexCom-Abbott 'legal wrangling' unlikely resolved in short-term
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

ABT Abbott
$121.11 /

+0.61 (+0.51%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

ABT Abbott
$121.11 /

+0.61 (+0.51%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

ABT Abbott
$121.11 /

+0.61 (+0.51%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

ABT Abbott
$121.11 /

+0.61 (+0.51%)

Hot Stocks
Optinose completes patient recruitment in trial for XHANCE in chronic sinusitis » 08:20
07/30/21
07/30
08:20
07/30/21
08:20
OPTN

Optinose

$2.75 /

+0.05 (+1.85%)

Optinose announced it has…

Optinose announced it has successfully completed recruitment in the first of two pivotal clinical trials to evaluate the safety and efficacy of XHANCE nasal spray as a treatment for patients with chronic sinusitis."The completion of recruitment for this trial keeps us on track to have top-line results in the first quarter of 2022," said CEO Peter Miller. "Approximately 30 million adults in the U.S. suffer from CS and there are no FDA-approved drug treatments for the disease today. If successfully developed, we believe our business potential with XHANCE will expand multi-fold with the new indication in terms of the number of patients who can be reached promotionally, the size of the physician audience that can be productively engaged, and the potential for commercial partnerships."

ShowHide Related Items >><<
OPTN Optinose
$2.75 /

+0.05 (+1.85%)

OPTN Optinose
$2.75 /

+0.05 (+1.85%)

05/06/21 RBC Capital
Optinose price target lowered to $10 from $17 at RBC Capital
05/06/21 Cantor Fitzgerald
Optinose price target lowered to $12 from $18 at Cantor Fitzgerald
04/06/21 RBC Capital
Optinose transferred with an Outperform at RBC Capital
OPTN Optinose
$2.75 /

+0.05 (+1.85%)

  • 14
    Aug
OPTN Optinose
$2.75 /

+0.05 (+1.85%)

Recommendations
LabCorp price target raised to $330 from $297 at Deutsche Bank » 07:06
07/30/21
07/30
07:06
07/30/21
07:06
LH

LabCorp

$294.69 /

+11.245 (+3.97%)

Deutsche Bank analyst…

Deutsche Bank analyst Pito Chickering raised the firm's price target on LabCorp to $330 from $297 and keeps a Buy rating on the shares. The company "topped high" Q2 expectations and raised 2021 guidance, Chickering tells investors in a research note. The analyst expects both acquisitions and share buybacks to pick up, and says "solid execution should continue to support the stock."

ShowHide Related Items >><<
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

06:39 Today Mizuho
LabCorp price target raised to $318 from $310 at Mizuho
05/20/21 Argus
LabCorp price target raised to $295 from $270 at Argus
05/18/21 Wells Fargo
Amazon could have interest in diagnostics beyond COVID, says Wells Fargo
05/12/21 Mizuho
LabCorp price target raised to $310 from $267 at Mizuho
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

Recommendations
LabCorp price target raised to $318 from $310 at Mizuho » 06:39
07/30/21
07/30
06:39
07/30/21
06:39
LH

LabCorp

$294.69 /

+11.245 (+3.97%)

Mizuho analyst Ann Hynes…

Mizuho analyst Ann Hynes raised the firm's price target on LabCorp to $318 from $310 and keeps a Buy rating on the shares. The analyst cites the "strong" quarter and an increased outlook for Covid testing for the target raise.

ShowHide Related Items >><<
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

05/20/21 Argus
LabCorp price target raised to $295 from $270 at Argus
05/18/21 Wells Fargo
Amazon could have interest in diagnostics beyond COVID, says Wells Fargo
05/12/21 Mizuho
LabCorp price target raised to $310 from $267 at Mizuho
05/03/21 William Blair
LabCorp's Vectra deal likely not the last for this year, says William Blair
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

Recommendations
Alector selloff on AL001 readout surprising, says H.C. Wainwright » 06:18
07/30/21
07/30
06:18
07/30/21
06:18
ALEC

Alector

$24.06 /

-6.43 (-21.09%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Andrew Fein reiterates a Buy rating on Alector with a $41 price target saying he was surprised by yesterday's selloff in the shares following the Phase 2 data readout of AL001. Had Alector positioned the expectations based on the clinical endpoint data, investors may have reacted differently, Fein tells investors in a research note. A "three-point change" in the AL001 treatment arm speaks of the "robust" mechanism of action of the drug, says the analyst. Fein views the Phase 2 data as "encouraging."

ShowHide Related Items >><<
ALEC Alector
$24.06 /

-6.43 (-21.09%)

ALEC Alector
$24.06 /

-6.43 (-21.09%)

07/06/21 Citi
Alector price target raised to $43 from $31 at Citi
07/02/21 Goldman Sachs
GSK collaboration 'positive' for Alector, says Goldman Sachs
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
01/15/21 BofA
Alector reinstated with a Buy at BofA
ALEC Alector
$24.06 /

-6.43 (-21.09%)

ALEC Alector
$24.06 /

-6.43 (-21.09%)

Periodicals
Bayer setting aside additional funds to resolve Roundup litigation, WSJ reports » 06:12
07/30/21
07/30
06:12
07/30/21
06:12
BAYRY

Bayer

$15.13 /

+0.24 (+1.61%)

Bayer is setting aside…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

BAYRY Bayer
$15.13 /

+0.24 (+1.61%)

Yesterday
Conference/Events
Roche management to meet virtually with Wolfe Research » 17:30
07/29/21
07/29
17:30
07/29/21
17:30
RHHBY

Roche

$47.76 /

+0.12 (+0.25%)

Virtual Meeting to be…

Virtual Meeting to be held on August 3 hosted by Wolfe Research.

ShowHide Related Items >><<
RHHBY Roche
$47.76 /

+0.12 (+0.25%)

RHHBY Roche
$47.76 /

+0.12 (+0.25%)

07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
07/23/21 Barclays
Roche price target raised to CHF 395 from CHF 375 at Barclays
07/22/21 UBS
Roche price target raised to CHF 375 from CHF 330 at UBS
07/19/21 UBS
Roche price target raised to CHF 345 from CHF 330 at UBS
RHHBY Roche
$47.76 /

+0.12 (+0.25%)

RHHBY Roche
$47.76 /

+0.12 (+0.25%)

RHHBY Roche
$47.76 /

+0.12 (+0.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.